Stocktoria

BridgeBio Pharma, Inc. BBIO

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2019-06-27 · LEI

BridgeBio Pharma, Inc. statistics & valuation

Market cap$13.8B
P / S27.4×
FCF margin-89.0%
Net debt$1.4B
Enterprise value USD$15.2B
Earnings yield EBIT/EV-3.4%
Return on capital-80.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
20182019202020212022202320242025
Operating margin (%)
-656.40% -5752.00% -827.10% -659.60% -6528.80% -267.20% -104.20% 20182019202020212022202320242025
Return on equity (%)
20182019202020212022202320242025
Shares outstanding
92.1M 123.7M 122.8M 147.3M 150.6M 175.1M 190.0M 194.8M 20182019202020212022202320242025
Net debt ($)
-$381.6M -$268.4M -$262.2M $37.0M $54.3M $70.5M -$243.8M $1.44B 20182019202020212022202320242025
Share buybacks ($)
20182019202020212022202320242025
Return on assets (%)
20182019202020212022202320242025
Free cash flow margin (%)
-631.70% -4936.70% -733.20% -546.50% -5686.60% -235.10% -89.00% 20182019202020212022202320242025
Debt / equity (×)
0.14× 0.20× 0.88× 20182019202020212022202320242025
EPS ($)
-$3.80 -$3.90 -$3.26 -$3.95 -$2.88 -$3.78 20182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Operating margin-104.2%-267.2%-6528.8%-659.6%-827.1%-5752.0%-656.4%—
FCF margin-89.0%-235.1%-5686.6%-546.5%-733.2%-4936.7%-631.7%—
Debt / equity-0.96×-0.30×-0.33×-0.34×-0.49×0.88×0.20×0.14×
Current ratio2.774.673.324.526.586.729.4213.67

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.